SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001171843-18-002785
Filing Date
2018-04-17
Accepted
2018-04-17 16:05:29
Documents
5
Period of Report
2018-05-31
Effectiveness Date
2018-04-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A def14a_040518.htm DEF 14A 971471
2 GRAPHIC logo.jpg GRAPHIC 6888
3 GRAPHIC cheung_sig.jpg GRAPHIC 2554
4 GRAPHIC proxycard_1.jpg GRAPHIC 159547
5 GRAPHIC proxycard_2.jpg GRAPHIC 118684
  Complete submission text file 0001171843-18-002785.txt   1369026
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Filer) CIK: 0000898437 (see all company filings)

IRS No.: 043145961 | State of Incorp.: MA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-14027 | Film No.: 18759034
SIC: 3841 Surgical & Medical Instruments & Apparatus